COLO B — Coloplast A/S Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapFalling Star

Annual income statement for Coloplast A/S, fiscal year end - September 30th, DKK millions except per share, conversion factor applied.

	2021 September 30th	2022 September 30th	2023 September 30th	2024 September 30th	2025 September 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	19,426	22,579	24,500	27,030	27,874
Cost of Revenue
Gross Profit	13,313	15,529	16,328	18,269	18,945
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	13,271	16,121	17,693	19,692	20,719
Operating Profit	6,155	6,458	6,807	7,338	7,155
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	6,233	6,127	6,025	6,395	6,157
Provision for Income Taxes
Net Income After Taxes	4,825	4,706	4,783	5,052	3,636
Net Income Before Extraordinary Items
Net Income	4,825	4,706	4,783	5,052	3,636
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	4,825	4,706	4,783	5,052	3,636
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	23.4	23.7	22.3	22.3	17.5
Dividends per Share